Biosimilar partnerships and EU approvals surge, enhancing access to innovative treatments in immunology, oncology, and bone ...
Samsung Bioepis Co. Ltd. has announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', ...
Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...
Mark Cuban Cost Plus Drug Co. has added Starjemza, a biosimilar to Johnson & Johnson’s Stelara (ustekinumab), to its portfolio. The company, co-founded by billionaire entrepreneur Mark Cuban, is ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...
Talk about a shot in the dark. Experts are sounding the alarm about a growing number of Americans injecting themselves at home with so-called “Korean Botox,” drawn in by promises of smooth skin at a ...
Marie Neidert, 43, first started getting Botox about three years ago as a way to manage her migraines, but enjoyed the cosmetic side effects too. When the medspa she goes to switched to a different ...
Celltrion has obtained the Food and Drug Administration’s clearance for a new presentation of Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), in a 45mg/0.5ml solution in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback